Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study (2017)
Source: European Journal of Pharmacology. Unidade: IQ
Assunto: GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERGAMIN, Letícia Scussel et al. Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study. European Journal of Pharmacology, v. 811, p. 268-275, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2017.06.030. Acesso em: 21 maio 2024.APA
Bergamin, L. S., Figueiró, F., Dietrich, F., Manica, F. de M., Chiela, E. C. F., Mendes, F. B., et al. (2017). Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study. European Journal of Pharmacology, 811, 268-275. doi:10.1016/j.ejphar.2017.06.030NLM
Bergamin LS, Figueiró F, Dietrich F, Manica F de M, Chiela ECF, Mendes FB, Jandrey EHF, Lopes DV, Oliveira FH, Nascimento IC, Ulrich H, Battastini AMO. Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study [Internet]. European Journal of Pharmacology. 2017 ; 811 268-275.[citado 2024 maio 21 ] Available from: https://doi.org/10.1016/j.ejphar.2017.06.030Vancouver
Bergamin LS, Figueiró F, Dietrich F, Manica F de M, Chiela ECF, Mendes FB, Jandrey EHF, Lopes DV, Oliveira FH, Nascimento IC, Ulrich H, Battastini AMO. Interference of ursolic acid treatment with glioma growth: an in vitro and in vivo study [Internet]. European Journal of Pharmacology. 2017 ; 811 268-275.[citado 2024 maio 21 ] Available from: https://doi.org/10.1016/j.ejphar.2017.06.030